DRC to launch first phase of Mpox vaccination campaign amid ongoing outbreak
13 oC
13 oC
Güneşli
13 oC
Güneşli
The Democratic Republic of the Congo (DRC), the "epicenter" of Africa's ongoing Mpox outbreak, will begin the first phase of its vaccination campaign on October 2, the government announced.
The campaign, which will run until October 11, follows the receipt of over 265,000 vaccine doses from international partners.
The DRC has reported 21,813 suspected cases of Mpox, with 716 deaths recorded since the beginning of 2024, according to a report released Friday by the Congolese Ministry of Health. The country is responsible for approximately 90 percent of Mpox cases across Africa.
The vaccination campaign comes as the World Health Organization (WHO) approved the MVA-BN vaccine, developed by Bavarian Nordic, for its prequalification list, marking it as the first officially approved vaccine for Mpox. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
A 55-year-old man from Gölbaşı village in Sivas’ Zara district has become the sixth victim of Crimean-Congo Haemorrhagic Fever (CCHF) in the region this year, health authorities confirmed on Saturday.
Australia has recorded its first case of the mpox clade 1b variant, known to cause more severe illness, according to the Australian Centre for Disease Control (CDC).
Türkiye’s household landscape is undergoing significant changes, with the average household size shrinking, one-person households on the rise, and stark regional differences in family structures.
Türkiye witnessed a continued and alarming decline in fertility in 2024, according to the latest figures released by the Turkish Statistical Institute (TurkStat) on Tuesday.
